Thursday, July 3, 2025 7/3/2025

Integrative Physiology of Thyroid Hormone Receptors and Nuclear Receptor Corepressors

Award Number: R01DK043806
ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 06/01/1991
PERIOD OF PERFORMANCE END DATE: 04/30/2029

Group Awards By:

View Award Description

Integrative Physiology of Thyroid Hormone Receptors and Nuclear Receptor Corepressors - Project Summary/Abstract Thyroid hormone receptors (TRs) are nuclear receptors (NRs) that switch from transcriptional repressors to activators in response to thyroid hormone (TH), a powerful regulator of lipid and energy metabolism. Repression is mediated by NR corepressors NCOR1 and NCOR2/SMRT, which function in multiprotein complexes containing histone deacetylase 3 (HDAC3), whose catalytic activity requires interaction with NCOR1/2. This proposal focuses on mechanisms by which TH controls liver metabolism as well as non- canonical metabolic functions of NCOR1/2 and HDAC3. Specific Aim 1 is to determine the molecular mechanisms and role of thyroid hormone action in physiology and in non-alcoholic steatohepatitis (NASH). TRb agonists have great promise in the treatment of NASH, but the mechanisms by which they alleviate fatty liver, inflammation, and fibrosis are unclear. Preliminary data in mouse models demonstrate that many TH-regulated genes are dysregulated in NASH livers, with evidence of both hypo- and hyperthyroidism. We will use novel epitope-tagged TRb mice, functional genomics, and genomic region-specific proximity labelling to determine the mechanisms by which TH-regulated genes are dysregulated in NASH. Our preliminary data has also uncovered regulation of tryptophan (Trp) metabolism by both NASH and TH, and shown that TH upregulates anti-inflammatory kynurenine (Kyn) metabolites downstream of Trp. We will use metabolic flux analysis to understand these changes, and will determine the importance of Kyn metabolites in the improvement of NASH by TH. Specific Aim 2 is to elucidate the physiological functions of nuclear receptor corepressors in the liver. Preliminary data reveal that, in addition to repression of lipogenic genes, NCORs unexpectedly activate gluconeogenic genes via an unrecognized chromatin opening ability. We hypothesize that this is due to recruitment of chromatin remodelers, and will test this by utilizing a functional genomics approach, including ChIP-seq, GRO-seq, and ATAC-seq combined with ChIP-mass spec in novel mice with epitope-tagged NCORs. We will also use genomic region-specific proximity labelling to identify proteins that interact specifically with NCORs at positively regulated genes. In addition we will determine the mechanism underlying the regulation of gluconeogenesis by NCORs in the normal fasting response. Specific Aim 3 is to determine the mechanisms underlying enzyme-independent functions of HDAC3 in the liver. In liver, catalytically inactive HDAC3 can repress de novo lipogenesis and prevent hepatosteatosis, but the mechanisms are not known. We will test the hypothesis that this is due to novel protein interactions by combining functional genomics and proteomics using tagged wild type and mutant HDAC3. These innovative studies address major questions regarding the mechanisms of action of TRs, corepressors, and HDAC3 and will shed new light on the transcriptional and epigenomic control of metabolism in physiology as well as NASH and related metabolic disorders.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $585,267 )
2025	2025	TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE	3451 WALNUT ST STE 440A	PHILADELPHIA	PA	19104	PHILADELPHIA	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	001	34	5/14/2025	NON-COMPETING CONTINUATION	$585,267
2025	2022	TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE	3451 WALNUT ST STE 440A	PHILADELPHIA	PA	19104	PHILADELPHIA	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	32	2/12/2025	NON-COMPETING CONTINUATION	$0
														Subtotal = $585,267

Issue Date FY: 2024 ( Subtotal = $585,267 )
2024	2024	TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE	3451 WALNUT ST STE 440A	PHILADELPHIA	PA	19104	PHILADELPHIA	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	33	4/12/2024	COMPETING CONTINUATION	$585,267
														Subtotal = $585,267

Issue Date FY: 2022 ( Subtotal = $532,334 )
2022	2022	TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE	3451 WALNUT ST STE 440A	PHILADELPHIA	PA	19104	PHILADELPHIA	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	32	4/28/2022	NON-COMPETING CONTINUATION	$532,334
														Subtotal = $532,334

Issue Date FY: 2021 ( Subtotal = $578,340 )
2021	2021	TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE	3451 WALNUT ST STE 440A	PHILADELPHIA	PA	19104	PHILADELPHIA	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	31	4/28/2021	NON-COMPETING CONTINUATION	$578,340
														Subtotal = $578,340

Issue Date FY: 2020 ( Subtotal = $608,859 )
2020	2020	TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE	3451 WALNUT ST STE 440A	PHILADELPHIA	PA	19104	PHILADELPHIA	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	001	30	4/29/2020	NON-COMPETING CONTINUATION	$593,554
2020	2020	TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE	3451 WALNUT ST STE 440A	PHILADELPHIA	PA	19104	PHILADELPHIA	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	29	2/12/2020	SUPPLEMENT FOR EXPANSION	$15,305
														Subtotal = $608,859

Issue Date FY: 2019 ( Subtotal = $532,334 )
2019	2019	TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE	3451 WALNUT ST STE 440A	PHILADELPHIA	PA	19104	PHILADELPHIA	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	29	6/18/2019	NON-COMPETING CONTINUATION	$532,334
														Subtotal = $532,334

Issue Date FY: 2018 ( Subtotal = $532,658 )
2018	2018	TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE	3451 WALNUT ST	PHILADELPHIA	PA	19104	PHILADELPHIA	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	001	28	9/26/2018	COMPETING CONTINUATION	$324
2018	2018	TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE	3451 WALNUT ST	PHILADELPHIA	PA	19104	PHILADELPHIA	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	28	6/21/2018	COMPETING CONTINUATION	$532,334
														Subtotal = $532,658

Grand Total All Awards = $3,955,059

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Integrative Physiology of Thyroid Hormone Receptors and Nuclear Receptor Corepressors

Award Number: R01DK043806

ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 06/01/1991

PERIOD OF PERFORMANCE END DATE: 04/30/2029

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer